![The cover of the report book shows a cross-section of a mouse small intestine infected with Cryptosporidium parasites.](http://cdn-acquia.dundee.ac.uk/sites/default/files/styles/card/public/2023-06/wcair-front-cover.jpg?itok=DEKdLdHe&h=af0b33fe)
News
WCAIR has recently published its 6 year report, sharing our achievements since inception back in 2017.
News
WCAIR has recently published its 6 year report, sharing our achievements since inception back in 2017.
Press release
The importance of investing in Dundee’s Life Sciences Innovation District was highlighted as leaders of the city’s key institutions welcomed the publication of the Scottish Government’s Innovation Strategy.
News
CeTPD Outreach is a public engagement sub-team branching in the new Centre for Targeted Protein Degradation as part of the University’s School of Life Sciences.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
News
Review of the Year 20212 took place last week with the Dean, Julian Blow sharing the highlights of activity within the School from 2022.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Feature
A news update about the Magnificent Microbes event featuring a weeklong programme of activities that could be done in schools, with a ‘scientist Q&A’ via Teams video at the end of the week to wrap everything up.
Impact case study
Shaping the future of commercial drug development and driving global pharmaceutical investment.
Press release
The University of Dundee has been confirmed as one of the UK’s leading research centres for biological sciences, according to the results of the Research Excellence Framework (REF 2021)
Impact case study
Bringing about step-change in the diagnosis and treatment of neglected tropical diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Our green space provides an educational resource to learn both about the history of medicines, as well as the ground-breaking drug discovery work going on inside our building.
Press release
Mutations in PINK1 are the second most frequent cause of autosomal recessive early-onset Parkinson’s disease.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
Press release
Scientists at the University of Dundee and Harvard Medical School have identified the key targets of an enzyme that play a critical role in protecting the brain against the development of Parkinson’s disease.